Aprea Therapeutics Inc (APRE)
5.120
-0.23
(-4.30%)
USD |
NASDAQ |
Apr 22, 16:00
5.25
+0.13
(+2.54%)
After-Hours: 20:00
Aprea Therapeutics Price to Book Value: 1.64 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 1.64 |
| April 19, 2024 | 1.714 |
| April 18, 2024 | 1.797 |
| April 17, 2024 | 1.835 |
| April 16, 2024 | 1.874 |
| April 15, 2024 | 1.890 |
| April 12, 2024 | 1.829 |
| April 11, 2024 | 1.890 |
| April 10, 2024 | 1.986 |
| April 09, 2024 | 1.934 |
| April 08, 2024 | 1.986 |
| April 05, 2024 | 2.018 |
| April 04, 2024 | 1.976 |
| April 03, 2024 | 2.136 |
| April 02, 2024 | 2.114 |
| April 01, 2024 | 2.034 |
| March 28, 2024 | 2.143 |
| March 27, 2024 | 1.944 |
| March 26, 2024 | 1.896 |
| March 25, 2024 | 1.341 |
| March 22, 2024 | 1.349 |
| March 21, 2024 | 1.400 |
| March 20, 2024 | 1.433 |
| March 19, 2024 | 1.486 |
| March 18, 2024 | 1.444 |
| Date | Value |
|---|---|
| March 15, 2024 | 1.364 |
| March 14, 2024 | 1.170 |
| March 13, 2024 | 1.223 |
| March 12, 2024 | 1.358 |
| March 11, 2024 | 1.492 |
| March 08, 2024 | 1.572 |
| March 07, 2024 | 1.642 |
| March 06, 2024 | 1.827 |
| March 05, 2024 | 1.801 |
| March 04, 2024 | 1.851 |
| March 01, 2024 | 1.763 |
| February 29, 2024 | 1.865 |
| February 28, 2024 | 1.587 |
| February 27, 2024 | 1.602 |
| February 26, 2024 | 1.576 |
| February 23, 2024 | 1.596 |
| February 22, 2024 | 1.405 |
| February 21, 2024 | 1.384 |
| February 20, 2024 | 1.384 |
| February 16, 2024 | 1.284 |
| February 15, 2024 | 1.256 |
| February 14, 2024 | 1.316 |
| February 13, 2024 | 1.303 |
| February 12, 2024 | 1.411 |
| February 09, 2024 | 1.322 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3151
Minimum
May 18 2022
8.223
Maximum
Jul 01 2020
2.320
Average
1.364
Median
Price to Book Value Benchmarks
| NeuBase Therapeutics Inc | 0.1714 |
| Stoke Therapeutics Inc | 3.263 |
| Processa Pharmaceuticals Inc | 0.8873 |
| NovaBay Pharmaceuticals Inc | 1.600 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| Price | 5.120 |
| Earnings Yield | -77.93% |
| Market Cap | 27.80M |